At A Glance

Name: Fred Ledley

Title: Founder and chairman, Mygenome

Background: Founder, CSO, and director of Framingham Genomic Medicine — 1999-2001; President, CEO, and director of Variagenics — 1996-1999; VP research and development of GeneMedicine — 1993-1996; Professor of cell biology and pediatrics and Howard Hughes investigator, Baylor College of Medicine —1983-1995

Education: MD from Georgetown Medical School — 1978; BS in physical science from the University of Maryland, College Park — 1974

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

Sponsored by

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.